Boehringer Ingelheim Biopharmaceuticals China Rewarded
The International Society for Pharmaceutical Engineering (ISPE®) has honored Boehringer Ingelheim’s commercial manufacturing site OASIS in Shanghai with an award in the ‘Facility of the Year 2020’ program.
We received the prize with an ‘Honorable Mention’ recognizing successful projects that have overcome significant challenges in planning, implementation and delivery.
Boehringer Ingelheim is China’s first international provider of biopharmaceutical contract manufacturing solutions to its clients in China and all over the world. The modern commercial facility OASIS is the first and only in line with global standards set by a multinational pharma company in China.
Learn more about OASIS in our latest Whitepaper.
Boehringer Ingelheim BioXcellence™ offers reliable world-class biopharmaceuticals contract development and manufacturing services to the pharmaceutical and biotechnology industry.
Boehringer Ingelheim BioXcellence™ welcomes your inquiries, questions and feedback.